Viral Kansara

Company: Clearside Biomedical

Job title: Vice President, Preclinical Development

Seminars:

Suprachoroidal Gene Delivery for Chorioretinal Diseases: Advancements, Potential and Challenges 11:30 am

Microinjector-based suprachoroidal (SC) gene delivery for minimally invasive office-based gene therapy SCS Microinjector®-based AAV gene therapy: Preclinical and clinical safety, efficacy, and durability Non-viral particle-based SC gene delivery for repeatable gene therapy Challenges and future directionRead more

day: Day One 11th